These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7611995)

  • 61. Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress.
    Shytaj IL; Procopio FA; Tarek M; Carlon-Andres I; Tang HY; Goldman AR; Munshi M; Kumar Pal V; Forcato M; Sreeram S; Leskov K; Ye F; Lucic B; Cruz N; Ndhlovu LC; Bicciato S; Padilla-Parra S; Diaz RS; Singh A; Lusic M; Karn J; Alvarez-Carbonell D; Savarino A
    EMBO Mol Med; 2021 Aug; 13(8):e13901. PubMed ID: 34289240
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CD38 in the age of COVID-19: a medical perspective.
    Horenstein AL; Faini AC; Malavasi F
    Physiol Rev; 2021 Oct; 101(4):1457-1486. PubMed ID: 33787351
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Coronavirus infection and PARP expression dysregulate the NAD metabolome: An actionable component of innate immunity.
    Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C
    J Biol Chem; 2020 Dec; 295(52):17986-17996. PubMed ID: 33051211
    [TBL] [Abstract][Full Text] [Related]  

  • 64. NAD
    Xie N; Zhang L; Gao W; Huang C; Huber PE; Zhou X; Li C; Shen G; Zou B
    Signal Transduct Target Ther; 2020 Oct; 5(1):227. PubMed ID: 33028824
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of NAD+ as an ageing-related immunomodulator on COVID 19 infection: A hypothesis.
    Omran HM; Almaliki MS
    J Infect Public Health; 2020 Sep; 13(9):1196-1201. PubMed ID: 32534944
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coronavirus infection and PARP expression dysregulate the NAD Metabolome: an actionable component of innate immunity.
    Heer CD; Sanderson DJ; Voth LS; Alhammad YMO; Schmidt MS; Trammell SAJ; Perlman S; Cohen MS; Fehr AR; Brenner C
    bioRxiv; 2020 Oct; ():. PubMed ID: 32511303
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nicotinamide activates latent HIV-1 ex vivo in ART suppressed individuals, revealing higher potency than the association of two methyltransferase inhibitors, chaetocin and BIX01294.
    Samer S; Arif MS; Giron LB; Zukurov JPL; Hunter J; Santillo BT; Namiyama G; Galinskas J; Komninakis SV; Oshiro TM; Sucupira MC; Janini LM; Diaz RS
    Braz J Infect Dis; 2020; 24(2):150-159. PubMed ID: 32105620
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide.
    Song SB; Park JS; Chung GJ; Lee IH; Hwang ES
    Metabolomics; 2019 Oct; 15(10):137. PubMed ID: 31587111
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.
    Rajman L; Chwalek K; Sinclair DA
    Cell Metab; 2018 Mar; 27(3):529-547. PubMed ID: 29514064
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Exploring NAD+ metabolism in host-pathogen interactions.
    Mesquita I; Varela P; Belinha A; Gaifem J; Laforge M; Vergnes B; Estaquier J; Silvestre R
    Cell Mol Life Sci; 2016 Mar; 73(6):1225-36. PubMed ID: 26718485
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
    Bipath P; Levay PF; Viljoen M
    BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism.
    Vastag L; Koyuncu E; Grady SL; Shenk TE; Rabinowitz JD
    PLoS Pathog; 2011 Jul; 7(7):e1002124. PubMed ID: 21779165
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Poly(ADP-ribosylation) and apoptosis.
    Scovassi AI; Poirier GG
    Mol Cell Biochem; 1999 Sep; 199(1-2):125-37. PubMed ID: 10544961
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 76. COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?
    Novak Kujundžić R
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457123
    [TBL] [Abstract][Full Text] [Related]  

  • 77. HIV infection decreases intracellular nicotinamide adenine dinucleotide [NAD].
    Murray MF; Nghiem M; Srinivasan A
    Biochem Biophys Res Commun; 1995 Jul; 212(1):126-31. PubMed ID: 7611995
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nicotinamide inhibits HIV-1 in both acute and chronic in vitro infection.
    Murray MF; Srinivasan A
    Biochem Biophys Res Commun; 1995 May; 210(3):954-9. PubMed ID: 7763268
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.